Björn Tackenberg

T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosis

Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age‐ and <scp>BMI</scp> ‐Corrected <i>Z</i> Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis

Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis

Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis

K2P18.1 translates T cell receptor signals into thymic regulatory T cell development

Short term relapse risk after switching from fingolimod to ocrelizumab or cladribine - an international cohort study (1822)

Short term relapse risk after switching from natalizumab to ocrelizumab or cladribine – an international cohort study (1712)

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study

Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data

Is <i>APOE</i> ε4 associated with cognitive performance in early MS?

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)

Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus

Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie

PML risk stratification using anti-JCV antibody index and L-selectin

Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array

Aktuelles zur Therapieumstellung bei Multipler Sklerose